Christopher J. Wallick

680 total citations
21 papers, 516 citations indexed

About

Christopher J. Wallick is a scholar working on Molecular Biology, Epidemiology and Neurology. According to data from OpenAlex, Christopher J. Wallick has authored 21 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Neurology. Recurrent topics in Christopher J. Wallick's work include Influenza Virus Research Studies (4 papers), Neuroblastoma Research and Treatments (4 papers) and Respiratory viral infections research (3 papers). Christopher J. Wallick is often cited by papers focused on Influenza Virus Research Studies (4 papers), Neuroblastoma Research and Treatments (4 papers) and Respiratory viral infections research (3 papers). Christopher J. Wallick collaborates with scholars based in United States, Switzerland and Netherlands. Christopher J. Wallick's co-authors include André S. Bachmann, Bonnie J. Warn‐Cramer, Soeren Mattke, Tamás Borsics, Ying Liu, A. C. Becker, Hankyung Jun, Kendra D. Martyn, Chengshi Jin and Alan F. Lau and has published in prestigious journals such as Neurology, Cancer Research and Oncogene.

In The Last Decade

Christopher J. Wallick

20 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher J. Wallick United States 11 349 69 56 47 44 21 516
Juraj Osterman United States 16 215 0.6× 14 0.2× 30 0.5× 87 1.9× 25 0.6× 25 566
He Li China 12 123 0.4× 22 0.3× 31 0.6× 5 0.1× 22 0.5× 57 428
Lun Cai China 12 201 0.6× 10 0.1× 41 0.7× 12 0.3× 37 0.8× 31 656
Pamela Kell United States 12 188 0.5× 7 0.1× 26 0.5× 22 0.5× 12 0.3× 19 474
Sema Kalkan Uçar Türkiye 14 205 0.6× 37 0.5× 47 0.8× 29 0.6× 4 0.1× 86 632
Tamar Guetta‐Baranes United Kingdom 12 204 0.6× 52 0.8× 37 0.7× 12 0.3× 13 0.3× 19 535
Xiaoyu Tian China 10 222 0.6× 19 0.3× 12 0.2× 26 0.6× 33 0.8× 21 577
Linjing Zhang China 13 138 0.4× 156 2.3× 18 0.3× 13 0.3× 11 0.3× 54 463
Maria D. Donovan Ireland 11 218 0.6× 7 0.1× 61 1.1× 7 0.1× 24 0.5× 21 480
Simona Delli Carpini Italy 13 182 0.5× 19 0.3× 11 0.2× 6 0.1× 20 0.5× 28 612

Countries citing papers authored by Christopher J. Wallick

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Wallick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Wallick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Wallick more than expected).

Fields of papers citing papers by Christopher J. Wallick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Wallick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Wallick. The network helps show where Christopher J. Wallick may publish in the future.

Co-authorship network of co-authors of Christopher J. Wallick

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Wallick. A scholar is included among the top collaborators of Christopher J. Wallick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Wallick. Christopher J. Wallick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campbell, David J., Lisa Bloudek, Josh J. Carlson, et al.. (2024). Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessment. Journal of Managed Care & Specialty Pharmacy. 30(9). 1013–1024. 2 indexed citations
2.
Wallick, Christopher J., et al.. (2023). Impact of antiviral therapy on short‐ and long‐term outcomes of patients with chronic obstructive pulmonary disease after influenza infection. Influenza and Other Respiratory Viruses. 17(12). e13231–e13231. 1 indexed citations
3.
Mattke, Soeren, Hankyung Jun, Emily Chen, et al.. (2023). Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis. Alzheimer s Research & Therapy. 15(1). 128–128. 50 indexed citations
4.
Abbass, Ibrahim M., Dae Hee Choi, Christopher J. Wallick, & Sheila Seleri Assunção. (2023). Trends in Healthcare Resource Use Preceding Diagnosis of Alzheimer’s Disease Dementia. International Journal of Alzheimer s Disease. 2023. 1–10. 5 indexed citations
5.
Liu, Ying, Hankyung Jun, A. C. Becker, Christopher J. Wallick, & Soeren Mattke. (2023). Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population. The Journal of Prevention of Alzheimer s Disease. 11(1). 7–12. 31 indexed citations
6.
7.
Wallick, Christopher J., et al.. (2021). Short and long term impact of influenza infection on individuals with type 2 diabetes: Effect on healthcare utilization and diabetes complications. Diabetes Management. 11(2). 2 indexed citations
8.
Wallick, Christopher J., et al.. (2021). Healthcare Resource Use and Burden Associated with Influenza Transmission Among Household Members with a Primary Infection: Commercial Claims Data Analysis. ClinicoEconomics and Outcomes Research. Volume 13. 335–342. 4 indexed citations
9.
Wallick, Christopher J., et al.. (2018). 2347. Antiviral Use Is Associated With a Decrease in Rate of Influenza-Related Complications and Resource Utilization. Open Forum Infectious Diseases. 5(suppl_1). S698–S698. 1 indexed citations
10.
Halker, Rashmi, Stewart J. Tepper, Kenneth Shulman, & Christopher J. Wallick. (2016). Total Migraine Freedom for Breath Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder (AVP-825) vs 100 mg Oral Sumatriptan from the COMPASS Study of Acute Treatment of Migraine (P6.098). Neurology. 86(16_supplement). 1 indexed citations
11.
12.
Wallick, Christopher J., Ryan N. Hansen, Joanna Campbell, et al.. (2015). Comorbidity and Health Care Resource Use Among Commercially Insured Non-Elderly Patients With Diabetic Macular Edema. Ophthalmic surgery, lasers & imaging retina. 46(7). 744–751. 35 indexed citations
13.
Williams, Jennifer Stewart, Christopher J. Wallick, Julie Byles, & Christopher M. Doran. (2013). Assessing Patterns of Use of Cardio-Protective Polypill Component Medicines in Australian Women. Drugs & Aging. 30(3). 193–203. 1 indexed citations
14.
15.
16.
Wallick, Christopher J., et al.. (2007). Akt Phosphorylates Connexin43 on Ser373, a “Mode-1” Binding Site for 14-3-3. Cell Communication & Adhesion. 14(5). 211–226. 85 indexed citations
17.
Wallick, Christopher J., et al.. (2006). Genomic organization, expression profile, and characterization of the new protein PRA1 domain family, member 2 (PRAF2). Gene. 371(1). 154–165. 29 indexed citations
18.
Freitas, Tracey, et al.. (2006). Molecular dynamics and in vitro analysis of Connexin43: A new 14‐3‐3 mode‐1 interacting protein. Protein Science. 15(10). 2344–2355. 40 indexed citations
19.
Park, Daniel J., Christopher J. Wallick, B J Warn-Cramer, et al.. (2006). Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis. Cell Proliferation. 39(6). 599–609. 42 indexed citations
20.
Wallick, Christopher J., David J. Feith, Shannon M. Wilson, et al.. (2005). Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells. Oncogene. 24(36). 5606–5618. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juraj Osterman Breakdown of academic impact, for papers by He Li Breakdown of academic impact, for papers by Lun Cai Breakdown of academic impact, for papers by Pamela Kell Breakdown of academic impact, for papers by Sema Kalkan Uçar Breakdown of academic impact, for papers by Tamar Guetta‐Baranes Breakdown of academic impact, for papers by Xiaoyu Tian Breakdown of academic impact, for papers by Linjing Zhang Breakdown of academic impact, for papers by Maria D. Donovan Breakdown of academic impact, for papers by Simona Delli Carpini
Rankless by CCL
2026